Mounjaro vs Zepbound: Tirzepatide Pricing
Published 2026-07-03 · Updated 2026-07-08 · MetaDose Research
Free comparison
Compare GLP-1 providers & cash-pay options
See telehealth and pharmacy programs that may lower your monthly cost.
MetaDose may earn a fee through partner links. See our disclaimer.
Mounjaro and Zepbound are both tirzepatide from Eli Lilly. List prices are similar ($1,086–$1,112/month in 2026), but your cost depends on indication, insurance formulary, and LillyDirect cash programs.
List price comparison
Both medications list above $1,000/month without coverage. LillyDirect may offer Zepbound vials at $349/month for certain doses without insurance.
Insurance differences
Diabetes indication (Mounjaro) is more commonly covered than weight-loss indication (Zepbound), similar to the Ozempic/Wegovy split.
GLP-1 cost by state
Frequently Asked Questions
Is Mounjaro the same as Zepbound?
Both contain tirzepatide. Mounjaro is approved for Type 2 diabetes; Zepbound is approved for weight management.